Reducing the Reliance on Opioids for Cancer Pain: Is the Switch to Cannabis a Viable Option?
Articles discussing the use of cannabis as a substitute for opioids highlight the limitations of the existing scientific evidence in the field.
Cannabinoids
Nonmedical Prescription Opioid Use Motivated by Pain Relief in Adolescence Predicts Later SUD
A set of characteristics of nonmedical use of prescription opioids in adolescents may help identify youth at high risk for substance use disorder, including opioid misuse, in early midlife.
Cannabinoids May Be Effective on Experimental Pain Threshold and Tolerance, Not Intensity
Although cannabinoids were found to improve the pain experience in individuals subjected to experimental pain, they were not found to have analgesic effects on existing experimental pain, suggesting that these agents may modulate affective processes.
Endocannabinoids May Be Elevated in Women With Fibromyalgia
Women with fibromyalgia were found to have elevated levels of endocannabinoidome lipid mediators.
Cannabis Use High in Migraine
A high percentage of cannabis users take the drug to treat headache and probable migraine.
Many Oncologists Discuss, Recommend Medical Marijuana
Many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable about its utility.
Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
Patients who use medical marijuana may be more likely to use prescription drugs for both medical and nonmedical purposes.
Marijuana Legalization and Opioid Prescribing Rates
Implementing medical or adult-use marijuana laws may reduce the rate of opioid prescribing for Medicaid enrollees.
Despite Research Gap, Medical Marijuana Use Supported at End of Life in Pediatric Cancer
Since the legalization of medical marijuana, clinicians must come up with appropriate responses to requests for treatment in pediatric end-of-life settings.
Peripherally Acting Opioid and Cannabinoid May Be Effective for Neuropathic Pain
Cotargeting of peripheral μ-opioid and cannabinoid receptors was found to have a synergistic effect in reducing mechanical allodynia in a mouse model of neuropathic pain.
Next post in APS 2018
